Matthias Niedrig

Title: Matthias Niedrig: Innovator in Viral Detection and Vaccination

Introduction

Matthias Niedrig is a prominent inventor based in Berlin, Germany. He has made significant contributions to the fields of viral detection and vaccination, holding a total of 2 patents. His work focuses on innovative methods that enhance the detection of viruses and improve vaccination techniques.

Latest Patents

One of Niedrig's latest patents is a detection method for the Ljungan virus. This invention relates to a method for specifically detecting Ljungan virus (LV) using quantitative real-time reverse transcriptase PCR. The invention also includes kits designed for performing this detection method. Another notable patent is for an intranasal yellow fever vaccination. This invention encompasses vaccine preparations, pharmaceutical preparations, and methods for inducing protective immunity in humans using a live, attenuated yellow fever virus of strain D17, preferably administered intranasally. Additionally, the inventors have developed an assay for detecting the induction of both binding and neutralizing antibodies formed in a protective immune response in humans who have received this intranasal vaccine preparation.

Career Highlights

Throughout his career, Matthias Niedrig has worked with reputable organizations, including Deutsches Primatenzentrum GmbH and Apodemus Ab. His experience in these companies has allowed him to collaborate on various innovative projects that contribute to public health.

Collaborations

Niedrig has collaborated with notable colleagues such as Christiane Stahl-Hennig and Gerhard Hunsmann. These partnerships have furthered his research and development efforts in the field of virology.

Conclusion

Matthias Niedrig's contributions to viral detection and vaccination demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a key figure in the fight against viral diseases.